R.H. Belmaker

2.5k total citations
60 papers, 1.9k citations indexed

About

R.H. Belmaker is a scholar working on Psychiatry and Mental health, Molecular Biology and Genetics. According to data from OpenAlex, R.H. Belmaker has authored 60 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Psychiatry and Mental health, 16 papers in Molecular Biology and 12 papers in Genetics. Recurrent topics in R.H. Belmaker's work include Bipolar Disorder and Treatment (23 papers), Genetics and Neurodevelopmental Disorders (7 papers) and Treatment of Major Depression (6 papers). R.H. Belmaker is often cited by papers focused on Bipolar Disorder and Treatment (23 papers), Genetics and Neurodevelopmental Disorders (7 papers) and Treatment of Major Depression (6 papers). R.H. Belmaker collaborates with scholars based in Israel, United States and Australia. R.H. Belmaker's co-authors include Nitsan Kozlovsky, Ora Kofman, Galila Agam, Richard P. Ebstein, Galila Agam, Yuly Bersudsky, Yamima Osher, Joseph Levine, Ben‐Ami Sela and Jay F. Levine and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

R.H. Belmaker

59 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R.H. Belmaker Israel 25 719 652 459 325 206 60 1.9k
Yuly Bersudsky Israel 27 916 1.3× 390 0.6× 317 0.7× 246 0.8× 124 0.6× 89 1.8k
Maria Del Zompo Italy 30 1.4k 1.9× 496 0.8× 431 0.9× 575 1.8× 55 0.3× 111 2.4k
William T. Regenold United States 26 802 1.1× 517 0.8× 482 1.1× 141 0.4× 84 0.4× 54 2.3k
Lucio Tremolizzo Italy 26 431 0.6× 967 1.5× 551 1.2× 362 1.1× 73 0.4× 134 2.6k
Toshihito Suzuki Japan 27 438 0.6× 416 0.6× 463 1.0× 114 0.4× 63 0.3× 96 1.9k
Jun‐ichi Iga Japan 28 630 0.9× 698 1.1× 430 0.9× 268 0.8× 59 0.3× 105 2.2k
Walid Abi‐Saab United States 27 906 1.3× 787 1.2× 1.5k 3.2× 119 0.4× 298 1.4× 42 3.3k
Shinichiro Nanko Japan 34 974 1.4× 1.1k 1.6× 1.0k 2.3× 955 2.9× 114 0.6× 98 3.5k
Haşmet Hanağası Türkiye 28 359 0.5× 624 1.0× 470 1.0× 161 0.5× 65 0.3× 120 2.7k
Yoko Kinoshita Japan 28 395 0.5× 715 1.1× 616 1.3× 571 1.8× 32 0.2× 73 2.1k

Countries citing papers authored by R.H. Belmaker

Since Specialization
Citations

This map shows the geographic impact of R.H. Belmaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.H. Belmaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.H. Belmaker more than expected).

Fields of papers citing papers by R.H. Belmaker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.H. Belmaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.H. Belmaker. The network helps show where R.H. Belmaker may publish in the future.

Co-authorship network of co-authors of R.H. Belmaker

This figure shows the co-authorship network connecting the top 25 collaborators of R.H. Belmaker. A scholar is included among the top collaborators of R.H. Belmaker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.H. Belmaker. R.H. Belmaker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Toker, Lilah, et al.. (2013). Trehalose induced antidepressant-like effects and autophagy enhancement in mice. Psychopharmacology. 229(2). 367–375. 65 indexed citations
2.
Osher, Yamima & R.H. Belmaker. (2009). Omega‐3 Fatty Acids in Depression: A Review of Three Studies. CNS Neuroscience & Therapeutics. 15(2). 128–133. 27 indexed citations
3.
Shaltiel, Galit, Joseph Deutsch, С. И. Рапопорт, et al.. (2009). Is phosphoadenosine phosphate phosphatase a target of lithium’s therapeutic effect?. Journal of Neural Transmission. 116(11). 1543–1549. 7 indexed citations
4.
Meiri, Gal, et al.. (2009). Omega 3 Fatty Acid Treatment in Autism. Journal of Child and Adolescent Psychopharmacology. 19(4). 449–451. 51 indexed citations
5.
Heldman, Eliahu, et al.. (2008). Lithium preferentially inhibits adenylyl cyclase V and VII isoforms. The International Journal of Neuropsychopharmacology. 11(4). 533–9. 25 indexed citations
6.
Amar, Shirly, Galit Shaltiel, Alon Shamir, et al.. (2007). Possible involvement of post-dopamine D2 receptor signalling components in the pathophysiology of schizophrenia. The International Journal of Neuropsychopharmacology. 11(2). 197–205. 33 indexed citations
7.
Nadri, Carmit, Yuly Bersudsky, R.H. Belmaker, & Galila Agam. (2006). Elevated urinary ADAM12 protein levels in lithium-treated bipolar patients. Journal of Neural Transmission. 114(4). 473–477. 3 indexed citations
8.
Levine, Joseph, Ziva Stahl, Ben‐Ami Sela, et al.. (2006). Homocysteine-Reducing Strategies Improve Symptoms in Chronic Schizophrenic Patients with Hyperhomocysteinemia. Biological Psychiatry. 60(3). 265–269. 105 indexed citations
9.
Tessler, Ran J., Lior Cohen, Elad Lerer, et al.. (2006). Polymorphisms in the dopamine D4 receptor gene (DRD4) contribute to individual differences in human sexual behavior: desire, arousal and sexual function. Molecular Psychiatry. 11(8). 782–786. 88 indexed citations
10.
Osher, Yamima, Yuly Bersudsky, & R.H. Belmaker. (2005). Omega-3 Eicosapentaenoic Acid in Bipolar Depression. The Journal of Clinical Psychiatry. 66(6). 726–729. 80 indexed citations
11.
Levine, Jay F., Galila Agam, Ben‐Ami Sela, et al.. (2005). CSF homocysteine is not elevated in schizophrenia. Journal of Neural Transmission. 112(2). 297–302. 8 indexed citations
12.
Shaldubina, Alona, Haim Einat, Yuly Bersudsky, & R.H. Belmaker. (2005). Epi-inositol is ineffective in Porsolt Forced Swim Test model of depression. Neuropsychiatric Disease and Treatment. 1(2). 189–190. 2 indexed citations
13.
Levine, Joseph, Ben‐Ami Sela, Yamima Osher, & R.H. Belmaker. (2005). High homocysteine serum levels in young male schizophrenia and bipolar patients and in an animal model. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 29(7). 1181–1191. 50 indexed citations
14.
Agam, Galila, et al.. (2003). Lithium inhibitable enzymes in postmortem brain of bipolar patients. Journal of Psychiatric Research. 37(5). 433–442. 12 indexed citations
15.
Einat, Haim, Florence Clénet, Alona Shaldubina, R.H. Belmaker, & Michel Bourin. (2001). The antidepressant activity of inositol in the forced swim test involves 5-HT2 receptors. Behavioural Brain Research. 118(1). 77–83. 55 indexed citations
16.
Kozlovsky, Nitsan, R.H. Belmaker, & Galila Agam. (2000). Low GSK-3β Immunoreactivity in Postmortem Frontal Cortex of Schizophrenic Patients. American Journal of Psychiatry. 157(5). 831–833. 139 indexed citations
17.
Lubrich, Beate, Ora Kofman, Galila Agam, et al.. (1997). Lithium-induced inositol depletion in rat brain after chronic treatment is restricted to the hypothalamus. Molecular Psychiatry. 2(5). 407–412. 24 indexed citations
18.
Levine, Jay F., Alain Rapaport, Arnon Elizur, et al.. (1994). CSF inositol in schizophrenia and high-dose inositol treatment of schizophrenia. European Neuropsychopharmacology. 4(4). 487–490. 20 indexed citations
19.
Kofman, Ora & R.H. Belmaker. (1993). Biochemical, behavioral, and clinical studies of the role of inositol in lithium treatment and depression. Biological Psychiatry. 34(12). 839–852. 90 indexed citations
20.
Belmaker, R.H., et al.. (1992). INOSITOL PASSES THE BLOOD BRAIN BEHAVIOR SUFFICIENTLY TO REVERSE LITHIUM EFFECTS ON BEHAVIOR IN RATS. Clinical Neuropharmacology. 15. 606A–607A. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuly Bersudsky Breakdown of academic impact, for papers by Maria Del Zompo Breakdown of academic impact, for papers by William T. Regenold Breakdown of academic impact, for papers by Lucio Tremolizzo Breakdown of academic impact, for papers by Toshihito Suzuki Breakdown of academic impact, for papers by Jun‐ichi Iga Breakdown of academic impact, for papers by Walid Abi‐Saab Breakdown of academic impact, for papers by Shinichiro Nanko Breakdown of academic impact, for papers by Haşmet Hanağası Breakdown of academic impact, for papers by Yoko Kinoshita
Rankless by CCL
2026